Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥641.5bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥224.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥750.1bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥547.2bn2021-04-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥187.1bn2021-10-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥142.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥49.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥102.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥31.6bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥139.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥50.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥141.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥97.0bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥28.6bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥108.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥115.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥87.7bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥25.3bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥108.4bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥87.8bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥25.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥1.39Tat 2022-12-31Cons.Assets IFRS
Total assets¥1.36Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.29Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥787.0bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥846.6bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥605.6bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥480.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥395.5bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥604.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥510.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥479.1bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥175.7bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥211.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥302.6bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥275.1bnat 2021-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥54.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥169.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥115.3bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥37.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥71.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥57.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥112.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥9.3bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥85.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥90.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥68.192021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥19.662021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥85.042022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.62022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥90.172021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥68.162021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.652021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio43.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.1%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥15.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥110.7bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-12-31−¥917m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥48.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥157.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥31.7bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2021-04-01 → 2021-12-31¥91.6bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2021-04-01 → 2021-12-31−¥1.5bn
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2021-04-01 → 2021-12-31¥43.8bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥134.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 734
ItemContextValueUnit
Proceeds from sale of property plant and equipment inv cf IFRSCurrentYTDDuration19840000000JPY
Purchase of intangible assets inv cf IFRSPrior1YTDDuration-16717000000JPY
Purchase of intangible assets inv cf IFRSCurrentYTDDuration-15234000000JPY
Purchase of investment securities inv cf IFRSPrior1YTDDuration-273000000JPY
Purchase of investment securities inv cf IFRSCurrentYTDDuration-3583000000JPY
Proceeds from sale of investments inv cf IFRSPrior1YTDDuration7747000000JPY
Proceeds from sale of investments inv cf IFRSCurrentYTDDuration-JPY
Payments for acquisition of subsidiaries inv cf IFRSPrior1YTDDuration-21587000000JPY
Payments for acquisition of subsidiaries inv cf IFRSCurrentYTDDuration-3909000000JPY
Proceeds from sale of subsidiaries inv cf IFRSPrior1YTDDuration724000000JPY
Proceeds from sale of subsidiaries inv cf IFRSCurrentYTDDuration-JPY
Other inv cf IFRSPrior1YTDDuration760000000JPY
Other inv cf IFRSCurrentYTDDuration1116000000JPY
Net cash provided by used in investing activities IFRSPrior1YTDDuration-57124000000JPY
Net cash provided by used in investing activities IFRSCurrentYTDDuration-37860000000JPY
Net increase decrease in short term borrowings fin cf IFRSPrior1YTDDuration-5356000000JPY
Net increase decrease in short term borrowings fin cf IFRSCurrentYTDDuration-81000000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-12801000000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-14938000000JPY
Proceeds from issuance of bonds fin cf IFRSPrior1YTDDuration56161000000JPY
Proceeds from issuance of bonds fin cf IFRSCurrentYTDDuration-JPY
Redemption of bonds fin cf IFRSPrior1YTDDuration-JPY
Redemption of bonds fin cf IFRSCurrentYTDDuration-40000000000JPY
Repayments of long term borrowings fin cf IFRSPrior1YTDDuration-15006000000JPY
Repayments of long term borrowings fin cf IFRSCurrentYTDDuration-JPY
Dividends paid fin cf IFRSPrior1YTDDuration-15428000000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-17822000000JPY
Dividends paid to non controlling interests fin cf IFRSPrior1YTDDuration-188000000JPY
Dividends paid to non controlling interests fin cf IFRSCurrentYTDDuration-226000000JPY
Payments for purchase of treasury shares fin cf IFRSPrior1YTDDuration-1801000000JPY
Payments for purchase of treasury shares fin cf IFRSCurrentYTDDuration-33237000000JPY
Deposit for purchase of treasury shares fin cf IFRSPrior1YTDDuration-13199000000JPY
Deposit for purchase of treasury shares fin cf IFRSCurrentYTDDuration-6762000000JPY
Other fin cf IFRSPrior1YTDDuration-1695000000JPY
Other fin cf IFRSCurrentYTDDuration632000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-9313000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-112434000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration8793000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration4102000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration57612000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-91249000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior2YearInstant217478000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior1YearInstant302572000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior1QuarterInstant275090000000JPY
Cash and cash equivalents if different from bs balance IFRSCurrentQuarterInstant211323000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E02272-000EndoscopicSolutionsReportableSegmentMember333701000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E02272-000TherapeuticSolutionsReportableSegmentMember203714000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E02272-000OtherReportableSegmentMember9769000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReportableSegmentsMember547184000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass